Peti
Christopher J. Peti, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20090173985 | Dense arrays and charge storage devices - There is provided a monolithic three dimensional array of charge storage devices which includes a plurality of device levels, wherein at least one surface between two successive device levels is planarized by chemical mechanical polishing. | 07-09-2009 |
Philipp Peti, Ruesselsheim DE
Patent application number | Description | Published |
---|---|---|
20130158779 | METHOD FOR OPERATING A FAULT DIAGNOSIS SYSTEM OF A VEHICLE AND VEHICLE - A method for operating a fault diagnosis system of a vehicle is provided. The vehicle includes a plurality of electronic components and a plurality of vehicle systems. At least one of the plurality of vehicle systems can be operated by means of at least two of the plurality of electronic components. The method includes determining if at least one of the plurality of electronic components comprises a fault condition, and if it is determined that at least one of the plurality of electronic components comprises a fault condition, a determining as to which of the vehicle systems that is operable by means of the electronic component comprising the fault condition, has caused the fault condition. In addition, a determining of an identification code that is assigned to the vehicle system causing the fault condition, takes place. Furthermore, a storing of a fault entry that includes the identification code takes place. | 06-20-2013 |
Wolfgang Peti, Barrington, RI US
Patent application number | Description | Published |
---|---|---|
20160038571 | Method and compositions for treatment of calcineurin-related diseases - Therapeutic compositions for treatment of protein serine/threonine phosphatase-related diseases are obtained by engineering amino acid sequences that disrupt interaction between the protein serine/threonine phosphatase and a protein inhibitor and are provided herein. Calcineurin and PPI are examples of protein serine/threonine phosphatases. RCAN1 is an inhibitor of calcineurin and is overexpressed in patients with serious diseases, such as Down syndrome and Alzheimer's disease. Molecules that bind RCAN1 at regions that interact with calcineurin selectively modulate functions of calcineurin to treat these diseases. Methods of treating a subject for a protein serine/threonine phosphatase-related disease by administering a molecule having an amino acid sequence selected from the group of SEQ ID NOs: 1-19 are further provided. | 02-11-2016 |